首页> 外文期刊>The Journal of Urology >Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.
【24h】

Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.

机译:遗传性平滑肌瘤病和肾细胞癌:与侵袭性形式的遗传性肾癌相关的综合征。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Hereditary leiomyomatosis and renal cell cancer is a recently described hereditary cancer syndrome in which affected individuals are at risk for cutaneous and uterine leiomyomas, and kidney cancer. Our initial experience revealed the aggressive behavior of these renal tumors, often with early metastasis, despite small primary tumor size. We report the clinical characteristics and urological treatment of patients with hereditary leiomyomatosis and renal cell cancer associated renal tumors. MATERIALS AND METHODS: A total of 19 patients with hereditary leiomyomatosis and renal cell cancer associated renal tumors were evaluated. The 11 women and 8 men had a median age at diagnosis of 39 years (range 22 to 67), and a median clinical and radiological followup of 34 months (range 6 to 141). Hereditary leiomyomatosis and renal cell cancer manifestations in patients with renal tumors included cutaneous leiomyomas in 11 of 17 evaluable patients (65%) and uterine leiomyomas in 7 of 7 evaluable females (100%). RESULTS: Median pathological tumor size was 7.8 cm (range 1.5 to 20). Histological subtypes were consistent with hereditary leiomyomatosis and renal cell cancer renal carcinoma. Four of 7 patients with 2.0 to 6.7 cm T1 tumors had spread to regional lymph nodes or metastases at nephrectomy. Overall 9 of 19 patients (47%) presented with nodal or distant metastases. CONCLUSIONS: Renal tumors in patients with hereditary leiomyomatosis and renal cell cancer syndrome are significantly more aggressive than those in patients with other hereditary renal tumor syndromes. In contrast to other familial renal cancer syndromes, the observation of 3 cm or less renal tumors associated with hereditary leiomyomatosis and renal cell cancer is not recommended. Careful followup of affected and at risk individuals in families is necessary.
机译:目的:遗传性平滑肌瘤病和肾细胞癌是最近描述的遗传性癌症综合症,其中受影响的个体有患皮肤和子宫平滑肌瘤和肾癌的风险。我们的初步经验表明,尽管原发灶较小,但这些肾肿瘤的侵袭性行为通常具有早期转移。我们报告了遗传性平滑肌瘤病和肾细胞癌相关性肾肿瘤患者的临床特征和泌尿外科治疗。材料与方法:评估了19例遗传性平滑肌瘤病和与肾细胞癌相关的肾肿瘤的患者。 11名女性和8名男性在诊断时的中位年龄为39岁(22至67岁),临床和放射学随访的中位时间为34个月(6至141岁)。肾肿瘤患者的遗传性平滑肌瘤病和肾细胞癌表现包括17例可评估患者中的11例(65%)皮肤平滑肌瘤和7例可评估女性中7例(100%)子宫平滑肌瘤。结果:中位病理肿瘤大小为7.8 cm(范围1.5至20)。组织学亚型与遗传性平滑肌瘤病和肾细胞癌肾癌一致。 7例T1肿瘤为2.0至6.7 cm的患者中有4例在肾切除术中已扩散至局部淋巴结或转移灶。 19例患者中有9例(47%)出现了淋巴结转移或远处转移。结论:遗传性平滑肌瘤病和肾细胞癌综合征患者的肾肿瘤比其他遗传性肾肿瘤综合征患者的肾肿瘤更具侵袭性。与其他家族性肾癌综合征相反,不建议观察与遗传性平滑肌瘤病和肾细胞癌相关的3 cm以下的肾肿瘤。必须对家庭中受影响和处于危险中的个体进行仔细的随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号